The delay in introducing a new, safer blood coagulant for Hong Kong haemophiliacs was first challenged by the South China Morning Post in 1992. The newspaper launched a three-month campaign late that year that successfully helped 61 HIV-infected haemophiliacs, including 26 children, to obtain financial help from the government. Chris Patten, who was governor at the time, met some of the patients and decided to help. In March the following year, financial secretary Hamish Macleod announced the setting up of a $350 million Aids Trust Fund. Each patient confirmed as having been infected with HIV before 1985 was given financial help. During the campaign, the Post asked the government why Hong Kong patients were not supplied with heat-treated concentrate until August 1985, months after their overseas counterparts. A story that appeared on December 27, 1992, headlined 'Hong Kong's silent Aids sufferers'' said: 'It is claimed many haemophiliacs could have been saved if governments had replaced contaminated Factor VIII earlier with products which were heat-treated to kill the Aids virus.' In that story, the director of health at the time, Lee Shiu-hung, did not reveal the exact time when the government introduced heat-treated blood products. He would only say the product was 'made available'' in Hong Kong ahead of 'other countries' such as Britain. A study group on HIV infection of haemophiliacs was appointed by secretary for health and welfare Elizabeth Wong Chien Chi-lien on January 6, 1993 to carry out an independent investigation. It reached the following conclusions: It was highly likely that the factor VIII used in Hong Kong before 1985 had been contaminated with HIV; The medical authority in Hong Kong had acted promptly and prudently to contain the spread of HIV infection through blood and blood products; It was because of the actions taken, that Hong Kong was among the first countries to receive the supply of the new factor VIII.